arginyl-glycyl-aspartic acid and Cancer of Prostate

arginyl-glycyl-aspartic acid has been researched along with Cancer of Prostate in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (3.13)	18.2507
2000's	9 (28.13)	29.6817
2010's	22 (68.75)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Gu, T; Jiang, Q; Lu, Q; Meng, X; Ning, X; Shan, X; Zhang, J; Zhang, L	1
Jang, MK; Kim, YM; Park, SC	1
Curcio, A; K A Silva, A; Lalatonne, Y; Lefèvre, CT; Pignol, D; Plan Sangnier, A; Preveral, S; Wilhelm, C	1
Alavian, MR; Altieri, DC; FitzGerald, TJ; Goel, HL; Huang, J; Languino, LR; Vue, M; Wang, T	1
Bao, A; Cheng, Z; Cutler, CS; Jiang, L; Liu, H; Miao, Z; Ren, G; Shi, H	1
Albert, DH; Fox, GB; Ji, S; Liu, S; Luo, Y; Mudd, SR; Shao, G; Voorbach, MJ; Zhang, Y; Zhou, Y	1
Dai, J; Deng, Z; Yang, Y; Yu, K; Zhang, H	1
Bandari, RP; Durkan, K; Hoffman, TJ; Jiang, Z; Liu, L; Miao, Y; Reynolds, TS; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF	1
Kopeček, J; Peng, ZH	2
Chen, Z; Wang, F; Zhu, L	1
Braun, GB; de Mendoza, TH; French, RP; Kotamraju, VR; Lowy, AM; Ruoslahti, E; Sugahara, KN; Teesalu, T	1
Chen, L; Chen, Z; Wang, F; Zhang, R; Zhu, L	1
Hoffman, TJ; Lewis, MR; Liu, D; Miao, Y; Rold, TL; Schehr, R; Smith, CJ; Stott Reynolds, TJ; Xu, J	1
Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G	1
Hu, K; Huang, T; Liang, X; Nie, D; Tang, G; Tang, X; Wang, H; Yao, S	1
Cai, ZJ; Shen, YH; Su, Y; Wang, H; Xu, YP; Yang, F; Zhang, G; Zhao, A; Zhu, SX	1
Cao, Q; Chen, X; Li, ZB; Liu, S; Liu, Z; Wang, F	1
Bergey, EJ; Ding, H; Hu, R; Ji, W; Law, WC; Liu, L; Prasad, PN; Roy, I; Wu, F; Yong, KT; Zhao, L; Zhao, W	1
Chen, X; Hoffman, TJ; Jackson, AB; Nanda, PK; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF	1
Alloatti, D; Badaloni, E; Cabri, W; Castorina, M; Giannini, G; Pisano, C; Vesci, L	1
Cui, L; Jia, B; Jin, X; Li, F; Liu, Z; Wang, F	1
Ashley, JW; Cody, JJ; Douglas, JT; Feng, X; Lyons, GR; Meleth, S; Rivera, AA; Siegal, GP; Wang, M; Yang, SW	1
Ghandehari, H; Line, BR; McNeill, E; Mitra, A; Mulholland, J; Nan, A	1
Ghandehari, H; Line, BR; Mitra, A; Nan, A	1
Ghandehari, H; Line, BR; Mitra, A; Nan, A; Papadimitriou, JC	1
Doi, M; Hirohata, S; Hudson, BG; Kondo, S; Kusachi, S; Kyo, S; Miyoshi, T; Ninomiya, Y; Obika, M; Ogawa, H; Sado, Y; Shiratori, Y; Yonezawa, T	1
Ala-Opas, MY; Alfthan, H; Desmond, RA; Hakkarainen, T; Hemminki, A; Kanerva, A; Kangasniemi, L; Rajecki, M; Rintala, E; Sankila, A; Särkioja, M; Stenman, UH; Tenhunen, M	1
Goligorsky, MS; Romanov, VI	1
Alemany, R; Curiel, DT; Fueyo, J; Krasnykh, V; Reynolds, PN; Suzuki, K	1
Brite, KH; Chatterjee, S; Matsumura, A	1
Angelucci, A; Bologna, M; D'Andrea, G; Festuccia, C; Teti, A	1

Other Studies

32 other study(ies) available for arginyl-glycyl-aspartic acid and Cancer of Prostate

Article	Year
The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer. Biomaterials, 2019, Volume: 223 Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Nucleus; Humans; Integrin beta3; Kinetics; Ligands; Liposomes; Male; Mice; Oligopeptides; Peptides; Prostatic Neoplasms	2019
Targeted gene delivery of polyethyleneimine-grafted chitosan with RGD dendrimer peptide in α Carbohydrate polymers, 2017, Oct-15, Volume: 174 Topics: Animals; Cell Line, Tumor; Chitosan; Dendrimers; Gene Silencing; Gene Transfer Techniques; Humans; Integrins; Male; Mice; Oligopeptides; Polyethyleneimine; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Transfection; Xenograft Model Antitumor Assays	2017
Targeted thermal therapy with genetically engineered magnetite magnetosomes@RGD: Photothermia is far more efficient than magnetic hyperthermia. Journal of controlled release : official journal of the Controlled Release Society, 2018, 06-10, Volume: 279 Topics: Animals; Antineoplastic Agents; Female; Genetic Engineering; HeLa Cells; Hot Temperature; Humans; Magnetite Nanoparticles; Magnetosomes; Male; Mice; Mice, Nude; Oligopeptides; PC-3 Cells; Prostatic Neoplasms; Uterine Cervical Neoplasms	2018
α Molecular cancer research : MCR, 2019, Volume: 17, Issue:2 Topics: Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Integrin alphaVbeta3; Male; Oligopeptides; PC-3 Cells; Prostatic Neoplasms; Radiation Tolerance; RNA Interference; Survivin; Transfection	2019
177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma. Nuclear medicine communications, 2013, Volume: 34, Issue:9 Topics: Animals; Aza Compounds; Bombesin; Cell Line, Tumor; Dimerization; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Mice; Molecular Targeted Therapy; Oligopeptides; Prostatic Neoplasms; Radiation Dosage; Radiochemistry; Radioisotopes	2013
Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 346, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Dimerization; Female; Glioma; Humans; Indazoles; Integrin alphaVbeta3; Male; Mice; Mice, Nude; Multimodal Imaging; Oligopeptides; Organotechnetium Compounds; Peptides, Cyclic; Phenylurea Compounds; Positron-Emission Tomography; Prostatic Neoplasms; Protein-Tyrosine Kinases; Radiopharmaceuticals; Technetium; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays	2013
In vitro assessment of the dual-targeting behavior of a peptide-based magnetic resonance imaging contrast agent. International journal of molecular medicine, 2014, Volume: 33, Issue:1 Topics: Breast Neoplasms; CD13 Antigens; Cell Line, Tumor; Contrast Media; Female; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Male; Oligopeptides; Prostatic Neoplasms	2014
A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors. Nuclear medicine and biology, 2014, Volume: 41, Issue:2 Topics: Aminocaproic Acid; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Dimerization; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Male; Mice; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Receptors, Bombesin	2014
Synthesis and activity of tumor-homing peptide iRGD and histone deacetylase inhibitor valproic acid conjugate. Bioorganic & medicinal chemistry letters, 2014, Apr-15, Volume: 24, Issue:8 Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Histone Deacetylase Inhibitors; Humans; Male; Molecular Structure; Oligopeptides; Prostatic Neoplasms; Valproic Acid	2014
cRGD-conjugated magnetic-fluorescent liposomes for targeted dual-modality imaging of bone metastasis from prostate cancer. Journal of liposome research, 2015, Volume: 25, Issue:2 Topics: Bone Neoplasms; Cadmium Compounds; Diagnostic Imaging; Fluorescent Dyes; Humans; Liposomes; Magnetic Phenomena; Magnetite Nanoparticles; Male; Oligopeptides; Prostatic Neoplasms; Quantum Dots; Selenium Compounds	2015
Tumor-penetrating iRGD peptide inhibits metastasis. Molecular cancer therapeutics, 2015, Volume: 14, Issue:1 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell-Penetrating Peptides; Drug Delivery Systems; Humans; Male; Metal Nanoparticles; Mice; Mice, Nude; Neoplasm Metastasis; Neuropilin-1; Oligopeptides; Organ Specificity; Prostatic Neoplasms; Silver; Xenograft Model Antitumor Assays	2015
RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. Journal of controlled release : official journal of the Controlled Release Society, 2014, Dec-28, Volume: 196 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line; Cisplatin; Drug Delivery Systems; Humans; Infrared Rays; Liposomes; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pain; Particle Size; Prostatic Neoplasms; Quantum Dots; Sulfides; Survival Analysis	2014
Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy. Nuclear medicine and biology, 2015, Volume: 42, Issue:2 Topics: Animals; Bombesin; Cell Line, Tumor; Copper Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Male; Mice; Oligopeptides; Prostatic Neoplasms; Receptors, Bombesin; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; X-Ray Microtomography	2015
Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer. Journal of the American Chemical Society, 2015, Jun-03, Volume: 137, Issue:21 Topics: Acrylamides; Antibiotics, Antineoplastic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Carriers; Drug Screening Assays, Antitumor; Humans; Male; Matrix Metalloproteinase 2; Molecular Structure; Oligopeptides; Polymers; Prostatic Neoplasms; Structure-Activity Relationship	2015
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model. Nuclear medicine communications, 2015, Volume: 36, Issue:9 Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed	2015
In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:8 Topics: Animals; Biocompatible Materials; Bombesin; Copper Radioisotopes; Female; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Nitrophenols; Oligopeptides; Peptides; Positron-Emission Tomography; Prostatic Neoplasms; Quantum Dots; Receptors, Bombesin; Semiconductors; Spectrometry, Fluorescence; Tissue Distribution	2015
Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice. PloS one, 2016, Volume: 11, Issue:1 Topics: Adenoviridae; Adenovirus E1A Proteins; Adenovirus E1B Proteins; Animals; Cell Line, Tumor; Cytopathogenic Effect, Viral; Humans; In Vitro Techniques; Male; Mice; Mutation; Oligopeptides; Prostatic Neoplasms	2016
Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:7 Topics: Animals; Bombesin; Breast Neoplasms; Cell Line, Tumor; Copper Radioisotopes; Dimerization; Humans; Male; Metabolic Clearance Rate; Mice; Oligopeptides; Organ Specificity; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution	2009
Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers. Nanotechnology, 2011, Apr-22, Volume: 22, Issue:16 Topics: Cell Line, Tumor; Drug Carriers; Glioma; Humans; Male; Nanocapsules; Oligopeptides; Polyethylene Glycols; Polyglactin 910; Prostatic Neoplasms	2011
64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer. Nuclear medicine and biology, 2012, Volume: 39, Issue:3 Topics: Aminocaproic Acid; Animals; Binding, Competitive; Bombesin; Cell Line, Tumor; Coordination Complexes; Copper Radioisotopes; Glutamic Acid; Heterocyclic Compounds; Humans; Integrin alphaVbeta3; Male; Mice; Oligopeptides; Peptide Fragments; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution; Xenograft Model Antitumor Assays	2012
Camptothecins in tumor homing via an RGD sequence mimetic. Bioorganic & medicinal chemistry letters, 2012, Oct-15, Volume: 22, Issue:20 Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Integrins; Male; Oligopeptides; Ovarian Neoplasms; Prostatic Neoplasms; Rats	2012
Evaluation of 188Re-MAG2-RGD-bombesin for potential prostate cancer therapy. Nuclear medicine and biology, 2013, Volume: 40, Issue:2 Topics: Animals; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Dipeptides; Humans; Male; Mice; Oligopeptides; Prostatic Neoplasms; Radiochemistry; Radioisotopes; Radiometry; Radionuclide Imaging; Receptors, Peptide; Rhenium	2013
Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model. Laboratory investigation; a journal of technical methods and pathology, 2013, Volume: 93, Issue:3 Topics: Adenoviridae; Analysis of Variance; Animals; Bone Neoplasms; Cell Line, Tumor; Humans; Immunoglobulin G; Luciferases; Male; Mice; Oligopeptides; Oncolytic Virotherapy; Osteoclasts; Osteoprotegerin; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; X-Ray Microtomography	2013
Targeting tumor angiogenic vasculature using polymer-RGD conjugates. Journal of controlled release : official journal of the Controlled Release Society, 2005, Jan-20, Volume: 102, Issue:1 Topics: Animals; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Humans; Male; Mice; Mice, SCID; Neovascularization, Pathologic; Oligopeptides; Polymers; Prostatic Neoplasms; Xenograft Model Antitumor Assays	2005
Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:9 Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Humans; Integrin alphaVbeta3; Male; Metabolic Clearance Rate; Methacrylates; Mice; Mice, SCID; Neovascularization, Pathologic; Oligopeptides; Organ Specificity; Prostatic Neoplasms; Radionuclide Imaging; Tissue Distribution	2005
Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapy. Nuclear medicine and biology, 2006, Volume: 33, Issue:1 Topics: Animals; Drug Carriers; Humans; Male; Metabolic Clearance Rate; Methacrylates; Mice; Mice, SCID; Neovascularization, Pathologic; Oligopeptides; Organ Specificity; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy; Technetium; Tissue Distribution; Treatment Outcome; Yttrium Radioisotopes	2006
Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:11 Topics: Adenoviridae; Animals; Autoantigens; Cell Division; Cell Line; Cell Line, Tumor; Cell Survival; Collagen Type IV; DNA-Binding Proteins; Endothelium, Vascular; Fibrosarcoma; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Oligopeptides; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Transfection; Transplantation, Heterologous; Umbilical Veins	2006
Treatment of prostate cancer with Ad5/3Delta24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivo. Molecular cancer therapeutics, 2007, Volume: 6, Issue:2 Topics: Adenoviridae; Animals; Cell Survival; Cells, Cultured; Chorionic Gonadotropin; Coxsackie and Adenovirus Receptor-Like Membrane Protein; DNA, Viral; Genetic Therapy; Genetic Vectors; Humans; Kidney; Lung Neoplasms; Male; Mice; Mice, Nude; Oligopeptides; Oncolytic Virotherapy; Prostatic Neoplasms; Receptors, Virus; Tumor Cells, Cultured; Virus Replication; Xenograft Model Antitumor Assays	2007
RGD-recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro. The Prostate, 1999, Volume: 39, Issue:2 Topics: Amino Acid Sequence; Cell Communication; Endothelium; Humans; Integrins; Male; Oligopeptides; Prostatic Neoplasms; Tumor Cells, Cultured	1999
A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:1 Topics: Adenoviridae; Adenovirus E1A Proteins; Animals; Cell Division; Female; Formazans; Genetic Vectors; Humans; Immunologic Tests; In Vitro Techniques; Luciferases; Lung Neoplasms; Male; Mice; Mice, Nude; Oligopeptides; Prostatic Neoplasms; Retinoblastoma Protein; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Virus Replication; Viruses	2001
Induction of apoptosis of integrin-expressing human prostate cancer cells by cyclic Arg-Gly-Asp peptides. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrins; Male; Oligopeptides; Peptides, Cyclic; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Vitronectin; Tumor Cells, Cultured	2001
Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators. Biological chemistry, 2002, Volume: 383, Issue:1 Topics: Chemotaxis; Dose-Response Relationship, Drug; Humans; Male; Neoplasm Invasiveness; Oligopeptides; Osteopontin; Plasminogen Activators; Prostatic Neoplasms; Receptors, Vitronectin; Sialoglycoproteins; Tumor Cells, Cultured; Up-Regulation; Urokinase-Type Plasminogen Activator	2002